optimizing the continuum of care for patients with pancreatic cancer: a case study-based debate
Published 7 years ago • 750 plays • Length 1:20:05Download video MP4
Download video MP3
Similar videos
-
12:08
pancreatic cancer debate: optimal therapy - adjuvant folfirinox
-
18:33
debate: how to treat borderline, resectable pancreatic cancer? - chemotherapy alone
-
13:42
debate: optimal neoadjuvant strategy in pancreatic cancer - chemotherapy alone
-
10:22
resectable pancreatic cancer debate: total neoadjuvant vs adjuvant therapy - total neoadjuvant
-
10:50
resectable pancreatic cancer debate: total neoadjuvant vs adjuvant therapy - adjuvant therapy
-
7:54
pancreatic cancer debate: optimal therapy - preoperative chemo/chemoradiotherapy
-
23:48
improving the outcome of patients with metastatic pancreatic cancer
-
15:55
improving the outcome of patients with metastatic pancreatic cancer
-
10:56
debate: optimal adjuvant chemotherapy for resected pancreatic cancer - gemcitabine/capecitabine
-
10:28
debate: treatment for resectable pancreatic cancer? - surgery adjuvant chemotherapy
-
28:39
new treatment options in pancreatic cancer
-
10:42
brca pancreatic cancer maintenance debate: parp inhibitor or continued chemo? - parp inhibitor
-
10:52
debate: optimal neoadjuvant strategy in pancreatic cancer - preoperative chemotherapy radiation
-
5:23
debate: optimal therapy for patients with resectable pancreatic cancer - neoadjuvant chemotherapy
-
19:23
new approaches in metastatic pancreatic cancer
-
12:43
debate: treatment for resectable pancreatic cancer? - neo-adjuvant chemotherapy
-
12:37
debate 10: what do we do after folfirinox? - gemcitabine is standard
-
23:29
all about nutrition for patients with pancreatic cancer
-
31:54
pancreatic cancer breakout: new potential in pancreatic cancer